Complex sugar-protein molecules that sense external messages to help a cell grow or respond to its environment can now be ...
No gene acts alone: interacting variants and protein partnerships can worsen, mask or even rescue disease risk, demanding ...
Scribe expects to initiate a first-in-human hypercholesterolemia study in mid-2026 with STX-1150, its lead cardiometabolic assetSTX-1150 is designed to deliver durable therapeutic LDL-C lowering with ...
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...
Rapid policy shifts, sustainability targets, and process-level innovations have fundamentally reshaped the global biofuel ...
Johns Hopkins researchers developed lipid nanoparticles to deliver therapeutic mRNA directly to the endometrium in mice. The ...
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine — which designs ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment FDA's Fast Track designation for ateganosine ...
The Healthy @Reader's Digest on MSN
Science: If you do this when you pass gas, it could actually be good for your brain
It’s…not a pleasant thought, but maybe it’s a little like the recent research that suggested 90% of us pick our noses in ...
News-Medical.Net on MSN
COVID-19 severity is linked to changes in mitochondrial DNA methylation
This study examined mitochondrial and nuclear-encoded mitochondrial DNA methylation in Indian patients with severe COVID-19 ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback